Phenominer Database Results (28 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
GH/Omr kidney wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 21 1.22 g 0.01 0.05 post excision weight measurement ng/kg/min 11525 101
BN.GH-(D6Mit12-D6Rat15)/Mcwi heart left ventricle wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 16 1.17 g 0.06 0.23 post excision weight measurement 0.0 ng/kg/min 68331 101
BN.GH-(D2Rat22-D2Mgh11)/Mcwi heart left ventricle wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 19 1.13 g 0.03 0.15 post excision weight measurement 0.0 ng/kg/min 68330 101
BN.GH-(D2Rat22-D2Mgh11)/Mcwi kidney wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 19 1.15 g 0.03 0.15 post excision weight measurement ng/kg/min 11532 101
BN.GH-(D6Mit12-D6Rat15)/Mcwi body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132.0 days-146.0 days 16 299.9 g 6.0 24.0 body weighing method 11541 101
GH/Omr heart left ventricle wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 21 1.69 g 0.03 0.13 post excision weight measurement 0.0 ng/kg/min 68329 101
BN/Elh heart left ventricle weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 21 3.7 mg/g 0.13 0.6 post excision weight measurement 0.0 ng/kg/min Original CMO ID was CMO:0000540. Corrected 2-15-2018. 68338 101
BN/Elh change in heart rate to change in vasoactive chemical dose ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart pumping trait male 132.0 days-146.0 days 14 -2.28 (beats/min)/(ug/kg) 0.07 0.26 vascular indwelling catheter method 0.0 ng/kg/min change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) 138470 101
BN.GH-(D18Rat41-D18Mgh4)/Mcwi change in heart rate to change in vasoactive chemical dose ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart pumping trait male 132.0 days-146.0 days 11 -1.25 (beats/min)/(ug/kg) 0.05 0.17 vascular indwelling catheter method 0.0 ng/kg/min change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) 138469 101
BN.GH-(D2Rat22-D2Mgh11)/Mcwi body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132.0 days-146.0 days 19 330.6 g 5.96 26.0 body weighing method 11534 101
BN.GH-(D18Rat41-D18Mgh4)/Mcwi kidney wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 21 1.17 g 0.04 0.2 post excision weight measurement ng/kg/min 11546 101
BN.GH-(D18Rat41-D18Mgh4)/Mcwi body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132.0 days-146.0 days 21 315.2 g 5.24 24.0 body weighing method 11548 101
BN/Elh single kidney wet weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 21 3.6 g/kg 0.09 0.4 post excision weight measurement ng/kg/min kidney wet weight to body weight ratio (CMO:0003389) 11554 101
BN/Elh body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132.0 days-146.0 days 21 310.3 g 7.64 35.0 body weighing method 11555 101
GH/Omr heart left ventricle weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 21 4.7 mg/g 0.15 0.7 post excision weight measurement 0.0 ng/kg/min Original CMO ID was CMO:0000540. Corrected 2-15-2018. 68334 101
BN.GH-(D18Rat41-D18Mgh4)/Mcwi heart left ventricle weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 21 3.7 mg/g 0.07 0.3 post excision weight measurement 0.0 ng/kg/min Original CMO ID was CMO:0000540. Corrected 2-15-2018. 68337 101
GH/Omr single kidney wet weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 21 3.4 g/kg 0.04 0.2 post excision weight measurement ng/kg/min kidney wet weight to body weight ratio (CMO:0003389) 11526 101
BN.GH-(D2Rat22-D2Mgh11)/Mcwi single kidney wet weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 19 3.7 g/kg 0.07 0.3 post excision weight measurement 0.0 ng/kg/min kidney wet weight to body weight ratio (CMO:0003389) 11533 101
BN.GH-(D6Mit12-D6Rat15)/Mcwi kidney wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 16 1.12 g 0.05 0.2 post excision weight measurement ng/kg/min 11539 101
BN.GH-(D6Mit12-D6Rat15)/Mcwi single kidney wet weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 16 3.7 g/kg 0.1 0.4 post excision weight measurement ng/kg/min kidney wet weight to body weight ratio (CMO:0003389) 11540 101
BN/Elh kidney wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 21 1.12 g 0.02 0.1 post excision weight measurement ng/kg/min 11553 101
BN/Elh heart left ventricle wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 21 1.15 g 0.03 0.13 post excision weight measurement 0.0 ng/kg/min 68333 101
BN.GH-(D2Rat22-D2Mgh11)/Mcwi heart left ventricle weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 19 3.4 mg/g 0.11 0.5 post excision weight measurement 0.0 ng/kg/min Original CMO ID was CMO:0000540. Corrected 2-15-2018. 68335 101
BN.GH-(D6Mit12-D6Rat15)/Mcwi heart left ventricle weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 16 3.8 mg/g 0.08 0.3 post excision weight measurement 0.0 ng/kg/min Original CMO ID was CMO:0000540. Corrected 2-15-2018. 68336 101
GH/Omr body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132.0 days-146.0 days 21 365.4 g 3.71 17.0 body weighing method 11527 101
BN.GH-(D18Rat41-D18Mgh4)/Mcwi single kidney wet weight to body weight ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. kidney mass male 132.0 days-146.0 days 21 3.8 g/kg 0.09 0.4 post excision weight measurement ng/kg/min kidney wet weight to body weight ratio (CMO:0003389) 11547 101
BN.GH-(D18Rat41-D18Mgh4)/Mcwi heart left ventricle wet weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart left ventricle mass male 132.0 days-146.0 days 21 1.15 g 0.04 0.2 post excision weight measurement 0.0 ng/kg/min 68332 101
GH/Omr change in heart rate to change in vasoactive chemical dose ratio angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. heart pumping trait male 132.0 days-146.0 days 14 -0.87 (beats/min)/(ug/kg) 0.07 0.25 vascular indwelling catheter method 0.0 ng/kg/min change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) 138468 101